Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 1
| |||||||
Iovance Biotherapeutics, Inc.
| 250K |
$9.15 | $2,287,500.00 | +356.38% | 320.15K |
Feb 20
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 6
| |||||||
Iovance Biotherapeutics, Inc.
| 10K |
$5.56 | $55,600.00 | +4.19% | 248.63K |
Sep 18
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Research Solutions, Inc.
| 50K |
$1.15 | $57,500.00 | +21.31% | 284.61K |
Jan 16
| |||||||
Iovance Biotherapeutics, Inc.
| 10K |
$6.15 | $61,500.00 | +16.63% | 70.15K |
Dec 21
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 8
| |||||||
Iovance Biotherapeutics, Inc.
| 10K |
$6.31 | $63,100.00 | +4.37% | 238.63K |
Nov 29
| |||||||
Iovance Biotherapeutics, Inc.
| 10K |
$6.18 | $61,800.00 | +4.57% | 228.63K |
Nov 28
| |||||||
Iovance Biotherapeutics, Inc.
| 40K |
$5.65 | $226,000.00 | +198.51% | 60.15K |
Aug 23
| |||||||
Research Solutions, Inc.
| 50K |
$1.19 | $59,500.00 | +27.08% | 234.61K |
Nov 5
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Iovance Biotherapeutics, Inc.
| 20K |
$6.82 | $136,400.00 | +9.14% | 238.78K |
May 31
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 8
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 29
| |||||||
Research Solutions, Inc.
| 7.5K |
$1.25 | $9,375.00 | +4.23% | 184.61K |
Jun 7
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 17
| |||||||
Research Solutions, Inc.
| 50K |
$1.25 | $62,500.00 | +39.34% | 177.11K |
Oct 9
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 12
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 652 |
—
|
—
| +1.03% | 63.91K |
Feb 15
| |||||||
Iovance Biotherapeutics, Inc.
| 10K |
$9.63 | $96,273.00 | +2.24% | 456.58K |
Dec 13
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 729 |
—
|
—
| +1.17% | 63.26K |
Nov 15
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 13
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 724 |
—
|
—
| +1.17% | 62.53K |
Aug 15
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 17
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 5.87K |
—
|
—
| +10.50% | 61.81K |
May 15
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 951 |
—
|
—
| +1.73% | 55.93K |
Feb 15
| |||||||
Lilis Energy, Inc.
| 38.22K |
—
|
—
| +8.91% | 466.92K |
Jan 31
| |||||||
Research Solutions, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 21
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 909 |
—
|
—
| +1.68% | 54.98K |
Nov 15
| |||||||
Lilis Energy, Inc.
| 22.5K |
—
|
—
| +5.54% | 428.7K |
Oct 17
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 756 |
—
|
—
| +1.42% | 54.07K |
Aug 15
| |||||||
Lion Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 3.19K |
—
|
—
| +6.36% | 53.32K |
May 15
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 4.08K |
$22.03 | $89,992.55 | +8.87% | 50.13K |
May 4
| |||||||
Aerojet Rocketdyne Holdings, Inc.
| 1.07K |
—
|
—
| +2.37% | 46.05K |
Feb 15
| |||||||
Lilis Energy, Inc.
| 18.33K |
—
|
—
| +4.73% | 406.2K |
Jan 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.